翔宇药业 (832276.oc)

+ 收藏

资产负债表(翔宇药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
流动资产:
 货币资金(元) 51,460,480.208,511,958.6757,010,948.4627,879,022.25
 应收票据及应收账款(元) 161,951,223.63161,453,283.38158,607,140.82165,885,220.02
  其中:应收票据(元) 25,800,000.00--3,225,432.08
  其中:应收账款(元) 136,151,223.63161,453,283.38158,607,140.82162,659,787.94
 预付款项(元) 41,078,416.3047,732,578.6037,406,253.8555,441,751.93
 其他应收款(元) 49,681,080.7711,319,961.885,380,208.962,690,380.00
 存货(元) 139,327,306.57177,000,768.53142,061,103.75139,071,912.50
 其他流动资产(元) 480.00480.00480.00940,457.62
 流动资产合计(元) 450,130,291.21413,165,977.98422,556,267.96403,938,126.45
非流动资产:
 固定资产(元) 308,760,501.56324,125,647.01330,389,132.30336,395,200.58
 使用权资产(元) 1,358,174.491,591,004.401,823,834.312,056,664.22
 无形资产(元) 107,689,385.68114,677,761.25115,335,073.44118,723,550.61
 开发支出(元) 64,260,552.9760,989,477.5264,568,367.9771,464,098.07
 递延所得税资产(元) 32,894,886.1031,094,719.4930,529,682.0117,281,235.54
 其他非流动资产(元) 16,252,965.6020,077,913.1029,277,913.103,608,087.10
 非流动资产合计(元) 531,216,466.40552,556,522.77571,924,003.13549,528,836.12
资产总计(元) 981,346,757.61965,722,500.75994,480,271.09953,466,962.57
流动负债:
 短期借款(元) 192,900,000.00142,900,000.00182,900,000.00182,900,000.00
 应付票据及应付账款(元) 32,364,647.4048,943,985.5849,678,997.2753,076,062.41
  其中:应付票据(元) 501,428.001,445,183.781,540,419.55838,631.77
  其中:应付账款(元) 31,863,219.4047,498,801.8048,138,577.7252,237,430.64
 合同负债(元) 12,723,586.3037,545,561.7143,501,403.4610,619,509.52
 应付职工薪酬(元) 1,954,045.865,369,984.617,316,744.762,077,542.51
 应交税费(元) 10,886,986.996,093,119.2324,771,600.8218,119,689.84
 其他应付款(元) 30,719,870.2542,215,975.2628,711,860.8535,953,694.99
 一年内到期的非流动负债(元) 550,458.72550,458.72550,458.72550,458.72
 其他流动负债(元) 1,654,066.115,655,182.445,655,182.442,310,065.89
 流动负债合计(元) 283,753,661.63289,274,267.55343,086,248.32305,607,023.88
非流动负债:
 租赁负债(元) 908,951.311,363,701.991,363,701.99898,398.94
 专项应付款(元) -642,663.01642,663.01929,135.60
 递延收益(元) 8,190,242.356,035,967.666,875,967.667,032,091.17
 递延所得税负债(元) 203,726.17---
 非流动负债合计(元) 9,302,919.838,042,332.668,882,332.668,859,625.71
负债合计(元) 293,056,581.46297,316,600.21351,968,580.98314,466,649.59
所有者权益(或股东权益):
 实收资本或股本(元) 191,726,000.00191,726,000.00191,726,000.00191,726,000.00
 资本公积(元) 193,294,752.02194,134,752.02193,294,752.02193,294,752.02
 盈余公积(元) 15,776,222.0515,776,222.0515,776,222.0515,776,222.05
 未分配利润(元) 286,989,012.82266,066,248.55240,958,444.68237,328,103.98
 归属于母公司股东权益合计(元) 687,785,986.89667,703,222.62641,755,418.75638,125,078.05
 少数股东权益(元) 504,189.26702,677.92756,271.36875,234.93
 股东权益合计(元) 688,290,176.15668,405,900.54642,511,690.11639,000,312.98
负债和股东权益合计(元) 981,346,757.61965,722,500.75994,480,271.09953,466,962.57
公告日期 2024-04-192023-08-252023-04-262022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院